WST
WST
US9553061055
West Pharmaceutical Services, I
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
25.76B EUR
25.27B EUR
17.77B EUR
19.82B EUR
Enterprise Value
25.45B EUR
25.15B EUR
17.57B EUR
19.35B EUR
Valuation Multiples
Trailing P/E
46.86x
44.74x
32.74x
49.08x
Forward P/E
36.66x
--
--
--
Price to Sales
7.74x
7.6x
5.52x
8.34x
Price to Book
8.62x
8.45x
5.94x
6.24x
EV/Revenue
7.65x
7.56x
5.45x
8.14x
EV/EBITDA
27.9x
27.32x
19.89x
29.69x
Price to FCF (P/FCF)
92.67x
57.85x
38.8x
48.25x
EV/FCF
91.55x
57.56x
38.35x
47.11x
FCF Yield
1.08%
1.73%
2.58%
2.07%
ende